Clinical Trial Update: Nitrous Oxide for Major Depressive Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for nitrous oxide targeting major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder
• Major Depressive Disorder

Drugs mentioned

• Nitrous oxide (nitrous oxide)

Snippet

Sponsor: Lingjiang Li | Conditions: Depressive Disorder, Major Depressive Disorder | Phase 2 | Status: COMPLETED